Prudential Financial Inc Clovis Oncology, Inc. Transaction History

Prudential Financial Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 07, 2018	BUY	$29.37 - $49.48 $1.11 Million - $1.87 Million	37,720 Added 55.68%	105,469 $0
Q2 2018 Aug 13, 2018	BUY	$42.06 - $62.4 $321,338 - $476,736	7,640 Added 12.71%	67,749 $0
Q1 2018 May 04, 2018	BUY	$50.12 - $67.72 $469,574 - $634,468	9,369 Added 18.46%	60,109 $0
Q4 2017 Feb 13, 2018	SELL	$57.69 - $84.58 $912,655 - $1.34 Million	-15,820 Reduced 23.77%	50,740 $3.45 Million
Q3 2017 Nov 02, 2017	BUY	$67.17 - $84.81 $4.47 Million - $5.64 Million	66,560	66,560 $5.49 Million

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Prudential Financial Inc with notifications on news.